10x (TXG) stock outlook | institutional activity and market reaction remain in focus. Shares of 10x Genomics Inc. (TXG) climbed 3.97% to close at $24.62, rallying from recent lows. The stock is testing the lower end of its resistance zone near $25.85 after finding strong support at $23.39. Trading volume was elevated, suggesting renewed buyer interest in the single-cell analysis specialist.
10x Genomics (TXG) Surges 3.97% – Key Resistance in Sight - {个股副标题}
TXG - Stock Analysis
3635 Comments
1108 Likes
1
{用户名称}
{用户等级}
2 hours ago
{协议答案}
👍 87
Reply
2
{用户名称}
{用户等级}
5 hours ago
{协议答案}
👍 201
Reply
3
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 184
Reply
4
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 138
Reply
5
{用户名称}
{用户等级}
2 days ago
{协议答案}
👍 161
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.